Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.
Also called NCT04181996
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 115 participants
- Registry
-
NCT04181996
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT04181996. Randomized; quadruple masking; primary purpose treatment. Start 2020-08-01 (actual); primary completion 2025-12-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
- Acronym
- CADENCE
- Condition
- Cardiovascular Diseases
- Condition
- Atherosclerosis
- Condition
- Inflammation
- Condition
- Diabetes
- Intervention (Drug)
- Colchicine Oral Product
- Intervention (Drug)
- Placebo oral capsule
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct04181996- Content hash
cc896e37e98c1cc8976bdfe05b7fb616eea15ee1fbb2d7f69a546cf990d28ba2